CMPR
Cimpress plc
CMPR offers stronger fundamentals, but that advantage does not outweigh its weaker overall profile.
META
Meta Platforms, Inc.
META has the edge over CMPR overall, supported by stronger modeled upside and lower modeled downside.
CMPR Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Stable | |
| Under pressure |
CMPR's profitability is currently healthy, and its revenue and cash flow are stable, but its balance sheet is under pressure.
META Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Stable | |
| Healthy |
META's revenue, profitability and balance sheet are currently healthy, and its cash flow is stable.
CMPR PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 11x | $36.09 | -36% |
| Current | 17x | $56.43 | — |
| Fair | 26x | $89.07 | +58% |
| Expensive | 60x | $202 | +258% |
Historical ranges are pointers, not guarantees.
CMPR's PE is in its fair range at 17x.
META PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 19x | $624 | — |
| Cheap | 21x | $613 | -1.7% |
| Current | 21x | $624 | — |
| Fair | 27x | $803 | +29% |
| Expensive | 32x | $934 | +50% |
Historical ranges are pointers, not guarantees.
META has the edge over CMPR in the historical PE scenario, which offers more potential upside but is not a forecast.
CMPR Forward outlook
There aren't enough analyst estimates for CMPR to show an outlook.
META Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Strong growth | |
| Strongly weakening | |
| Moderate | |
| Low |
Analysts expect earnings and revenue growth for META, but weaker profitability. However, they disagree widely on these estimates.
CMPR Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $3.38 | +145% |
| Q2 2026 | $3.79 | +553% |
| Q1 2026 | $1.85 | -68% |
| Q4 2025 | $0.97 | -84% |
| Q3 2025 | $1.38 | -76% |
| Q2 2025 | $0.58 | -91% |
| Q1 2025 | $5.80 | +78% |
| Q4 2024 | $5.98 | +291% |
CMPR's earnings per share have fallen from their peak: $3.38 over the past year, against $8.77 in late 2019.
META Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $32.16 | +9.7% |
| Q3 2026 | $29.32 | +30% |
| Q2 2026 | $26.54 | -3.7% |
| Q1 2026 | $27.50 | +7.5% |
| Q4 2025 | $23.49 | -1.6% |
| Q3 2025 | $22.58 | +6.5% |
| Q2 2025 | $27.56 | +41% |
| Q1 2025 | $25.58 | +47% |
| Q4 2024 | $23.86 | +60% |
META has the edge over CMPR on earnings, with more consistent year-over-year improvement.
CMPR Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $934.1M | +8.2% |
| Q2 2026 | $945M | +8.7% |
| Q1 2026 | $886.2M | +12% |
| Q4 2025 | $1B | +11% |
| Q3 2025 | $863.3M | +7.2% |
| Q2 2025 | $869.5M | +4.4% |
| Q1 2025 | $789.5M | +1.1% |
| Q4 2024 | $939.2M | +1.9% |
CMPR's revenue has grown year over year for 15 quarters in a row: $934M last quarter, up 8.2% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 2.8% | -2.9 points |
| Q2 2026 | 6.9% | -0.7 points |
| Q1 2026 | 5.5% | +0.4 points |
| Q4 2025 | 8.4% | -0.2 points |
| Q3 2025 | 5.7% | +0.8 points |
| Q2 2025 | 7.5% | -0.4 points |
| Q1 2025 | 5.1% | +0.1 points |
| Q4 2024 | 8.6% | -3.1 points |
CMPR's operating margin was 2.8% last quarter, down 2.9 points from the same quarter a year ago.
META Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $64.6B | +26% |
| Q2 2026 | $60.8B | +28% |
| Q1 2026 | $56.3B | +33% |
| Q4 2025 | $59.9B | +24% |
| Q3 2025 | $51.2B | +26% |
| Q2 2025 | $47.5B | +22% |
| Q1 2025 | $42.3B | +16% |
| Q4 2024 | $48.4B | +21% |
META has the edge over CMPR on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | -20 points |
| Q2 2026 | 31% | -12 points |
| Q1 2026 | 41% | -0.9 points |
| Q4 2025 | 41% | -7 points |
| Q3 2025 | 40% | -2.7 points |
| Q2 2025 | 43% | +5 points |
| Q1 2025 | 41% | +3.6 points |
| Q4 2024 | 48% | +7.4 points |
META has the edge over CMPR on profitability, with a higher operating margin.
CMPR Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $6.1M | +$7.4M |
| Q2 2026 | $84.8M | -2.1% |
| Q1 2026 | -$39.5M | -$24.4M |
| Q4 2025 | $139.5M | -7.1% |
| Q3 2025 | -$1.3M | +$11.3M |
| Q2 2025 | $86.7M | -24% |
| Q1 2025 | -$15.1M | -$13.1M |
| Q4 2024 | $150.1M | -8.2% |
CMPR still generates free cash flow, though less than at its 2019 peak: $191M over the past year.
META Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.2B | -110% |
| Q2 2026 | $1.7B | -81% |
| Q1 2026 | $13.2B | +19% |
| Q4 2025 | $14.8B | +9.3% |
| Q3 2025 | $11.2B | -32% |
| Q2 2025 | $9B | -19% |
| Q1 2025 | $11.1B | -14% |
| Q4 2024 | $13.6B | +16% |
META has the edge over CMPR on cash flow, with more consistent year-over-year improvement.
CMPR Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -3.3% | -842K shares |
| 1 year | -2.3% | -567K shares |
| 3 years | -9.6% | -2.6M shares |
| 5 years | -7.9% | -2.1M shares |
| Available history | -12% | -3.4M shares |
CMPR has the edge over META on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | $21.9M |
| Q4 2025 | $25.5M |
| Q3 2025 | $2.7M |
| Q2 2025 | $20.8M |
| Q1 2025 | $3.9M |
| Q4 2024 | $42.4M |
CMPR spent $47M buying back its own shares over the past year, down 32% from the year before.
META Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.3% | +7M shares |
| 1 year | 0% | +1M shares |
| 3 years | -2.6% | -68M shares |
| 5 years | -10% | -286M shares |
| Available history | -11% | -303M shares |
META has 2.6B diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | $3.3B |
| Q2 2025 | $10.2B |
| Q1 2025 | $12.8B |
| Q4 2024 | — |
META hasn't bought back shares in the past year.
CMPR Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 3.9x | Elevated |
| Q2 2026 | 3.4x | Elevated |
| Q1 2026 | 3.5x | Elevated |
| Q4 2025 | 3.5x | Elevated |
| Q3 2025 | 3.7x | Elevated |
| Q2 2025 | 3.7x | Elevated |
| Q1 2025 | 3.8x | Elevated |
| Q4 2024 | 3.7x | Elevated |
CMPR's net debt is about 3.9 years of its operating earnings (EBITDA), up from 3.7 years a year ago.
META Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.7x | Very low |
| Q2 2026 | 0.6x | Very low |
| Q1 2026 | 0.3x | Very low |
| Q4 2025 | 0.2x | Very low |
| Q3 2025 | 0.2x | Very low |
| Q2 2025 | 0.2x | Very low |
| Q1 2025 | 0.0x | Very low |
| Q4 2024 | -0.2x | Net Cash |
META has the edge over CMPR on leverage, with a lower net debt burden relative to earnings.
CMPR Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 28.6 | Oversold |
| Stochastic | 2.6 | Oversold |
CMPR's weekly RSI is 29 (oversold) and its Stochastic is 3 (oversold).
META Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 48.2 | Neutral |
| Stochastic | 33.7 | Neutral |
META's weekly RSI is 48 (neutral) and its Stochastic is 34 (neutral).
CMPR PE vs Communication Services Sector
| Metric | CMPR | Sector median | Relative |
|---|---|---|---|
| PE | 17x | 16x | 1.3% above |
| PE % | 38 | 26 | 12 pts above |
CMPR has the edge over META on valuation relative to its sector.
META PE vs Communication Services Sector
| Metric | META | Sector median | Relative |
|---|---|---|---|
| PE | 21x | 16x | 29% above |
| PE % | 18 | 26 | 8 pts below |
META is trading at 21x earnings, a 29% premium to the Communication Services sector's median of 16x.
CMPR Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $69.4 | 19% below |
| 20 week MA | $83.6 | 32% below |
| 50 week MA | $81.5 | 31% below |
| 100 week MA | $68.4 | 18% below |
| 200 week MA | $69.6 | 19% below |
CMPR is in a downtrend: it's below all five of its weekly moving averages, and 19% below its 200-week average.
META Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $674.9 | 7.6% below |
| 20 week MA | $634.5 | 1.7% below |
| 50 week MA | $630.8 | 1.1% below |
| 100 week MA | $647.8 | 3.7% below |
| 200 week MA | $517.5 | 21% above |
META has the edge over CMPR on trend strength, trading above more of its moving averages.
CMPR Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $126.4 | $86.6 | -31% |
| 2021 | $86.6 | $69.8 | -19% |
| 2022 | $69.8 | $27.1 | -61% |
| 2023 | $27.1 | $80.1 | +196% |
| 2024 | $80.1 | $72.2 | -9.8% |
| 2025 | $72.2 | $69.2 | -4.1% |
| 2026 YTD | $69.2 | $56.4 | -18% |
CMPR's yearly returns have swung widely, from +196% in 2023 to −61% in 2022. It's down 18% so far in 2026.
META Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $208.1 | $267.4 | +28% |
| 2021 | $267.4 | $335.2 | +25% |
| 2022 | $335.2 | $118.0 | -65% |
| 2023 | $118.0 | $354.0 | +200% |
| 2024 | $354.0 | $599.8 | +69% |
| 2025 | $599.8 | $663.3 | +11% |
| 2026 YTD | $663.3 | $623.6 | -6% |
META has the edge over CMPR on returns for 2026, with the stronger performance.